155 related articles for article (PubMed ID: 7097541)
1. Structure-activity relationship study of anthraquinones: 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethoxy)ethyl]amino]-9,10-anthracenedione, an analog of an established antineoplastic agent.
Zee-Cheng RK; Cheng CC
J Pharm Sci; 1982 Jun; 71(6):708-9. PubMed ID: 7097541
[TBL] [Abstract][Full Text] [Related]
2. Esters of 2-(1-hydroxyalkyl)-1,4-dihydroxy-9,10-anthraquinones with melphalan as multifunctional anticancer agents.
Jin G; You Y; Ahn B
Bioorg Med Chem Lett; 2001 Jun; 11(11):1473-6. PubMed ID: 11378380
[TBL] [Abstract][Full Text] [Related]
3. Structural modification study of mitoxantrone (DHAQ). Chloro-substituted mono- and bis[(aminoalkyl)amino]anthraquinones.
Zee-Cheng RK; Mathew AE; Xu PL; Northcutt RV; Cheng CC
J Med Chem; 1987 Sep; 30(9):1682-6. PubMed ID: 3625713
[TBL] [Abstract][Full Text] [Related]
4. Antitumor properties of tetrahydrobenz[a]anthraquinone derivatives.
Morreal CE; Bernacki RJ; Hillman M; Atwood A; Cartonia D
J Med Chem; 1990 Feb; 33(2):490-2. PubMed ID: 2299618
[TBL] [Abstract][Full Text] [Related]
5. Relationship of chemical structures of anthraquinones with their effects on the suppression of immune responses.
Wang BS; Murdock KC; Lumanglas AL; Damiani M; Silva J; Ruszala-Mallon VM; Durr FE
Int J Immunopharmacol; 1987; 9(6):733-9. PubMed ID: 2961707
[TBL] [Abstract][Full Text] [Related]
6. Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity.
Zee-Cheng RK; Podrebarac EG; Menon CS; Cheng CC
J Med Chem; 1979 May; 22(5):501-5. PubMed ID: 458801
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
Fujimoto S; Ogawa M
Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones.
Zee-Cheng RK; Cheng CC
J Med Chem; 1978 Mar; 21(3):291-4. PubMed ID: 628005
[TBL] [Abstract][Full Text] [Related]
9. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations.
Krapcho AP; Petry ME; Getahun Z; Landi JJ; Stallman J; Polsenberg JF; Gallagher CE; Maresch MJ; Hacker MP; Giuliani FC
J Med Chem; 1994 Mar; 37(6):828-37. PubMed ID: 8145234
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor properties of an anthraquinone bisubstituted by the copper chelating peptide Gly-Gly-L-His.
Morier-Teissier E; Boitte N; Helbecque N; Bernier JL; Pommery N; Duvalet JL; Fournier C; Hecquet B; Catteau JP; Hénichart JP
J Med Chem; 1993 Jul; 36(15):2084-90. PubMed ID: 8340911
[TBL] [Abstract][Full Text] [Related]
11. Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.
Showalter HD; Johnson JL; Hoftiezer JM; Turner WR; Werbel LM; Leopold WR; Shillis JL; Jackson RC; Elslager EF
J Med Chem; 1987 Jan; 30(1):121-31. PubMed ID: 3806589
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antineoplastic evaluation of 1,4-bis(aminoalkanamido)-9,10-anthracenediones.
Martelli S; Dzieduszycka M; Stefanska B; Bontemps-Gracz M; Borowski E
J Med Chem; 1988 Oct; 31(10):1956-9. PubMed ID: 3172129
[TBL] [Abstract][Full Text] [Related]
13. 6-[(aminoalkyl)amino]-substituted 7H-benzo[e]perimidin-7-ones as novel antineoplastic agents. Synthesis and biological evaluation.
Stefańska B; Dzieduszycka M; Martelli S; Tarasiuk J; Bontemps-Gracz M; Borowski E
J Med Chem; 1993 Jan; 36(1):38-41. PubMed ID: 8421288
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones.
Krapcho AP; Getahun Z; Avery KL; Vargas KJ; Hacker MP; Spinelli S; Pezzoni G; Manzotti C
J Med Chem; 1991 Aug; 34(8):2373-80. PubMed ID: 1875336
[TBL] [Abstract][Full Text] [Related]
15. Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicity.
Beggiolin G; Crippa L; Menta E; Manzotti C; Cavalletti E; Pezzoni G; Torriani D; Randisi E; Cavagnoli R; Sala F; Giuliani FC; Spinelli S
Tumori; 2001; 87(6):407-16. PubMed ID: 11989596
[TBL] [Abstract][Full Text] [Related]
16. [Formulation and antileukemic activity of quinolizidinylalkylaminic derivatives of naphthoquinone and anthraquinone].
Boido Canu C; Boido V; Sparatore F
Boll Chim Farm; 1989 Jun; 128(6):208-11. PubMed ID: 2619988
[TBL] [Abstract][Full Text] [Related]
17. 5-[(Aminoalkyl)amino]-substituted anthra[1,9-cd]pyrazol-6(2H)-ones as novel anticancer agents. Synthesis and biological evaluation.
Showalter HD; Johnson JL; Werbel LM; Leopold WR; Jackson RC; Elslager EF
J Med Chem; 1984 Mar; 27(3):253-5. PubMed ID: 6699870
[No Abstract] [Full Text] [Related]
18. Preparation and evaluation of 2-substituted anthraquinones based on the anthracyclines.
Bennett S; Sharples D; Brown JR
J Med Chem; 1982 Apr; 25(4):369-73. PubMed ID: 7069715
[TBL] [Abstract][Full Text] [Related]
19. Biologic and biochemical effects of mitoxantrone.
Durr FE
Semin Oncol; 1984 Sep; 11(3 Suppl 1):3-10. PubMed ID: 6484579
[TBL] [Abstract][Full Text] [Related]
20. 2-(1 -hydroxyiminoalkyl)-1 ,4-dimethoxy-9,10-anthraquinones: synthesis and evaluation of cytotoxicity.
Tam MN; Nam NH; Jin GZ; Ahn BZ
Arch Pharm Res; 2000 Aug; 23(4):283-7. PubMed ID: 10976572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
